Key result
Multidetector CT imaging provides a wide spectrum of findings crucial for identifying and differentiating benign and malignant thrombotic and embolic disease in cancer patients.
This pictorial review highlights the wide spectrum of multidetector CT findings for thrombotic and embolic disease in cancer patients, emphasizing clues for differentiating benign from malignant thrombi.
Answers are grounded in this paper and cite their sources.
May aid CT interpretation of cancer-associated thrombi; leaves open prospective validation before changing practice.
This article is a reasoned pictorial review illustrating the many faces of thrombotic and embolic disease developing in the cancer patient. From a clinical point of view, we particularly point out the importance of properly identifying this occurrence in its various presentations. From a radiological point of view, special emphasis is given to the wide spectrum of multidetector CT findings, to the clues of benign and malignant thrombus diagnosis, and to the potential interpretative pitfalls.
No takes yet. Share an insight, caveat, or question.
Catalano et al. (2011) conducted a review in Thrombotic and embolic disease in cancer patients. Multidetector CT was evaluated. Multidetector CT imaging provides a wide spectrum of findings crucial for identifying and differentiating benign and malignant thrombotic and embolic disease in cancer patients.
Synapse has enriched 10 related papers. Consider them for comparative context: